1xan
From Proteopedia
(New page: 200px<br /> <applet load="1xan" size="450" color="white" frame="true" align="right" spinBox="true" caption="1xan, resolution 2.0Å" /> '''HUMAN GLUTATHIONE RE...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1xan. | + | [[Image:1xan.jpg|left|200px]]<br /><applet load="1xan" size="350" color="white" frame="true" align="right" spinBox="true" |
| - | <applet load="1xan" size=" | + | |
caption="1xan, resolution 2.0Å" /> | caption="1xan, resolution 2.0Å" /> | ||
'''HUMAN GLUTATHIONE REDUCTASE IN COMPLEX WITH A XANTHENE INHIBITOR'''<br /> | '''HUMAN GLUTATHIONE REDUCTASE IN COMPLEX WITH A XANTHENE INHIBITOR'''<br /> | ||
| Line 8: | Line 7: | ||
==Disease== | ==Disease== | ||
| - | Known | + | Known diseases associated with this structure: Hemolytic anemia due to glutathione reductase deficiency OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=138300 138300]], Mental retardation, autosomal recessive, 6 OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=138244 138244]] |
==About this Structure== | ==About this Structure== | ||
| - | 1XAN is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with FAD and HXP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Glutathione-disulfide_reductase Glutathione-disulfide reductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.8.1.7 1.8.1.7] Full crystallographic information is available from [http:// | + | 1XAN is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=FAD:'>FAD</scene> and <scene name='pdbligand=HXP:'>HXP</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Glutathione-disulfide_reductase Glutathione-disulfide reductase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.8.1.7 1.8.1.7] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1XAN OCA]. |
==Reference== | ==Reference== | ||
| Line 26: | Line 25: | ||
[[Category: oxidoreductase]] | [[Category: oxidoreductase]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:08:37 2008'' |
Revision as of 15:08, 15 February 2008
|
HUMAN GLUTATHIONE REDUCTASE IN COMPLEX WITH A XANTHENE INHIBITOR
Contents |
Overview
We have determined the crystal structure of a complex between the, noncompetitive inhibitor (Kis = 27 microM, Kii = 48 microM with respect to, oxidized glutathione (GSSG) and Kis = 144 microM, Kii = 176 microM with, respect to NADPH) 6-hydroxy-3-oxo-3H-xanthene-9-propionic acid (XAN) and, human glutathione reductase (hGR). The structure, refined to an R-factor, of 0.158 at 2.0 A resolution, reveals XAN bound in the large cavity, present at the hGR dimer interface where it does not overlap the, glutathione binding site. The inhibitor binding causes extensive local, structural changes that primarily involve amino acid residues from a, 30-residue alpha-helix that lines the cavity and contributes to the active, site of hGR. Despite the lack of physical overlap of XAN with the GSSG, binding site, no GSSG binding is seen in soaks carried out with high XAN, and GSSG concentrations, suggesting that some subtle interaction between, the sites exists. An earlier crystallographic analysis on the complex, between hGR and 3,7-diamino-2,8-dimethyl-5-phenyl-phenazinium chloride, (safranin) showed that safranin bound at this same site. We have found, that safranin also inhibits hGR in a noncompetitive fashion, but it binds, about 16 times less tightly (Kis = 453 microM, Kii = 586 microM with, respect to GSSG) than XAN and does not preclude the binding of GSSG in the, crystal. Although in structure-based drug design competitive inhibitors, are usually targetted, XAN's binding to a well defined site that is unique, to glutathione reductase suggests that noncompetitive inhibitors could, also serve as lead compounds for structure-based drug design, in, particular as components of chimeric inhibitors.
Disease
Known diseases associated with this structure: Hemolytic anemia due to glutathione reductase deficiency OMIM:[138300], Mental retardation, autosomal recessive, 6 OMIM:[138244]
About this Structure
1XAN is a Single protein structure of sequence from Homo sapiens with and as ligands. Active as Glutathione-disulfide reductase, with EC number 1.8.1.7 Full crystallographic information is available from OCA.
Reference
Kinetics and crystallographic analysis of human glutathione reductase in complex with a xanthene inhibitor., Savvides SN, Karplus PA, J Biol Chem. 1996 Apr 5;271(14):8101-7. PMID:8626496
Page seeded by OCA on Fri Feb 15 17:08:37 2008
